VISTOGARD-4

Drug BTG International, Inc.
Total Payments
$25,210
Transactions
30
Doctors
17
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $25,210 30 17

Payments by Nature

Nature of Payment Amount Transactions Share
Space rental or facility fees (teaching hospital only) $13,025 7 51.7%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,350 4 45.0%
Travel and Lodging $536.76 3 2.1%
Food and Beverage $297.95 16 1.2%

Top Doctors Receiving Payments for VISTOGARD-4

Doctor Specialty Location Total Records
Unknown Boston, MA $13,025 7
, M.D Medical Oncology Ocala, FL $7,413 5
, M.D Internal Medicine Orange, CA $4,486 3
, MBBS Critical Care Medicine Jacksonville, FL $100.80 1
, D.M.D Orthodontics and Dentofacial Orthopedics Los Alamitos, CA $22.94 1
, MD Hematology & Oncology Durango, CO $14.56 1
, M.D Hematology & Oncology Henderson, NV $14.40 1
, MD Hematology & Oncology Baton Rouge, LA $13.56 1
, MD Medical Oncology Baton Rouge, LA $13.56 1
, MD Specialist Houston, TX $12.47 1
, MD Dermatology Lawton, OK $12.29 1
, MD Medical Oncology Lawton, OK $12.29 1
, MD Hematology & Oncology San Antonio, TX $12.29 1
, MD Hematology San Antonio, TX $12.29 1
, MD Hematology & Oncology San Antonio, TX $12.29 1
, M.D Hematology & Oncology Huntington Beach, CA $10.89 1
, M.D Medical Oncology San Diego, CA $10.78 1
, MD General Practice Lancaster, CA $10.33 1

About VISTOGARD-4

VISTOGARD-4 is a drug associated with $25,210 in payments to 17 healthcare providers, recorded across 30 transactions in the CMS Open Payments database. The primary manufacturer is BTG International, Inc..

Payment data is available from 2017 to 2017. In 2017, $25,210 was paid across 30 transactions to 17 doctors.

The most common payment nature for VISTOGARD-4 is "Space rental or facility fees (teaching hospital only)" ($13,025, 51.7% of total).